DoP proposes to oversee drug regulator

As the government plans a major overhaul of the country’s drug authority, the Department of Pharmaceuticals (DoP) has proposed to oversee Central Drugs Standard Control Organisation (CDSCO) to be transferred to it.

Concerns had been raised at the highest levels of the government over the ability of the regulatory framework to keep up with the demands of industry and scientists, triggering the move to revamp the drug authority,
according to media report.

According to the order accessed by ET, A committe had been constituted by the Cabinet secretary for reforming the drug regulatory system under the chairmanship of Sh. Rajesh Bhushan who will take over as health secretary from the present health secretary Preeti Sudan after three months. The committee will held a meeting on Friday.

In view od DoP, since it deals with the pharma industry the CSDCO should come under its ambit. According to the DoP, the same will cut down unnecessary time delay in giving approval to a drug or a vaccine.

According to the sources, “There are multiple agencies involved in the regulatory framework for a drug/vaccine approval. The DoP also has the National Pharmaceutical Pricing Authority under it. “
“The DoP has suggested that CDSCO be shifted under its charge.”

Source: ET

  • Related Posts

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

    Pak-made illegal cosmetics recovered from Itwari shop

    Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert